Predicted Trait | |
Reported Trait | Prostate cancer |
Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
Score Construction | |
PGS Name | pt_clump_nested.CV.GCST006085.Prostate_cancer |
Development Method | |
Name | pt_clump_nested.CV |
Parameters | p0.000001, r2 = 0.1, window = 250kb |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 765 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000517 |
Citation (link to publication) | Monti R et al. Am J Hum Genet (2024) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 9,671 individuals, 100.0 % Male samples |
European | UKB | — | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM019521 | PSS011221| European Ancestry| 68,516 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.65268 [1.5832893, 1.72511914] β: 0.5024 [0.45950452, 0.54529611] |
AUROC: 0.63839 [0.62689394, 0.64987964] | R²: 0.05647 [0.04798058, 0.06559575] | 0 | beta = log(or)/sd_pgs |
PPM019522 | PSS011232| European Ancestry| 171,474 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.82864 [1.7955911, 1.86229749] β: 0.60357 [0.58533427, 0.62181093] |
AUROC: 0.6649 [0.66024355, 0.66955943] | R²: 0.08013 [0.07594604, 0.0849066] | 0 | beta = log(or)/sd_pgs |
PPM019523 | PSS011245| South Asian Ancestry| 19,738 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.6915 [1.38133728, 2.07131408] β: 0.52562 [0.32305207, 0.72818323] |
AUROC: 0.63946 [0.58058365, 0.69834094] | R²: 0.04017 [0.01277226, 0.08063675] | 0 | beta = log(or)/sd_pgs |
PPM019524 | PSS011261| European Ancestry| 31,410 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.73299 [1.65753964, 1.81186867] β: 0.54985 [0.50533436, 0.59435873] |
AUROC: 0.65124 [0.6397176, 0.66276176] | R²: 0.06647 [0.05674221, 0.07746767] | 0 | beta = log(or)/sd_pgs |
PPM019526 | PSS011274| European Ancestry| 41,305 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.81235 [1.73744769, 1.89047452] β: 0.59462 [0.55241719, 0.63682787] |
AUROC: 0.66197 [0.65090246, 0.67303245] | R²: 0.07892 [0.06819253, 0.09030102] | 0 | beta = log(or)/sd_pgs |
PPM019525 | PSS011289| South Asian Ancestry| 4,976 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.09235 [1.73026328, 2.53021198] β: 0.73829 [0.54827358, 0.92830309] |
AUROC: 0.69188 [0.63818733, 0.74557944] | R²: 0.08168 [0.04043084, 0.13345443] | 0 | beta = log(or)/sd_pgs |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011274 | — | — | [ ,
100.0 % Male samples |
— | European | — | UKB | — |
PSS011245 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | G&H | — |
PSS011221 | — | — | [ ,
100.0 % Male samples |
— | European | — | EB | — |
PSS011289 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | UKB | — |
PSS011261 | — | — | [ ,
100.0 % Male samples |
— | European | — | HUNT | — |
PSS011232 | C3_PROSTATE, ICD10: C61, ICD9: 185 | — | [ ,
100.0 % Male samples |
— | European | — | FinnGen | — |